BMC medicine
Association between preoperative interruption of antiplatelet therapy and postoperative thrombotic risk after minimally invasive surgery for abdominopelvic cancer in patients treated with P2Y12 inhibitors.
Masashi Kubota, Satomi Yoshida, Takayuki Goto, Toshiki Fukasawa, Takayuki Anno, Gaku Fujiwara, Satoshi Toshiyama, Yoshihide Inayama, Takanori Yanai, Takayuki Sumiyoshi, Ryoichi Saito, Takashi Kobayashi, Koji Kawakami
Published: 202610.1186/s12916-026-04634-0
Abstract
BACKGROUND: The safety of preoperative discontinuation of antiplatelet therapy for arterial thrombotic complications in non-cardiac, high-bleeding-risk surgery among patients receiving P2Y12 inhibitors remains poorly understood. This study compares t…
Preview only. Read the full abstract at the source